Id proteins promote a cancer stem cell phenotype in triple negative breast cancer via negative regulation of Robo1
Wee S Teo,
Aurélie S Cazet,
Daniel L. Roden,
Christina Valbirk Konrad,
Binitha Anu Varghese,
Archana P. T.,
Jaynish S. Shah,
Laura A Baker,
Ewan K.A. Millar,
Mathew J Naylor,
Christopher J. Ormandy,
Sunil R Lakhani,
Albert S. Mellick,
Sandra A. O’Toole,
Posted 15 Dec 2018
bioRxiv DOI: 10.1101/497313
Posted 15 Dec 2018
Breast cancers display phenotypic and functional heterogeneity and several lines of evidence support the existence of cancer stem cells (CSCs) in certain breast cancers, a minor population of cells capable of tumor initiation and metastatic dissemination. Identifying factors that regulate the CSC phenotype is therefore important for developing strategies to treat metastatic disease. The Inhibitor of Differentiation Protein 1 (Id1) and its closely related family member Inhibitor of Differentiation 3 (Id3) (collectively termed Id) are expressed by a diversity of stem cells and are required for metastatic dissemination in experimental models of breast cancer. In this study, we show that ID1 is expressed in rare neoplastic cells within ER-negative breast cancers. To address the function of Id1 expressing cells within tumors, we developed two independent murine models of Triple Negative Breast Cancer (TNBC) in which a genetic reporter permitted the prospective isolation of Id1+ cells. Id1+ cells are enriched for self-renewal in tumorsphere assays in vitro and for tumor initiation in vivo . Conversely, depletion of Id1 and Id3 in the 4T1 murine model of TNBC demonstrates that Id1/3 are required for cell proliferation and self-renewal in vitro , as well as primary tumor growth and metastatic colonization of the lung in vivo . Using combined bioinformatic analysis, we have defined a novel mechanism of Id protein function via negative regulation of the Roundabout Axon Guidance Receptor Homolog 1 ( Robo1 ) leading to activation of a Myc transcriptional programme. * CSC : Cancer stem cell TNBC : Triple Negative Breast Cancer Id : Id1 and Id3
- Downloaded 1,496 times
- Download rankings, all-time:
- Site-wide: 10,042
- In cancer biology: 199
- Year to date:
- Site-wide: 21,335
- Since beginning of last month:
- Site-wide: 19,459
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!